AFFINIA THERAPEUTICS Trademark

Trademark Overview

On Tuesday, January 30, 2024, a trademark application was filed for AFFINIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AFFINIA THERAPEUTICS trademark a serial number of 98383240. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, August 23, 2024. This trademark is owned by Affinia Therapeutics Inc.. The AFFINIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
affinia therapeutics

General Information

Serial Number98383240
Word MarkAFFINIA THERAPEUTICS
Filing DateTuesday, January 30, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateFriday, August 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAdeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffinia Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Tuesday, January 30, 2024NEW APPLICATION ENTERED
Thursday, May 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2024ASSIGNED TO EXAMINER

Related Keywords

therapeutics affinia treatment preparations tissue associated disorders conditions vectors organs diseases muscles